ストックスクリーナーアプリを入手
1.194
2.59%
0.034
前日終値:
$1.16
開ける：
$1.18
24時間の取引高:
62,843
Relative Volume:
0.12
時価総額：
$2.43M
収益：
-
当期純損益:
$-9.82M
株価収益率:
-0.1489
EPS:
-8.02
ネットキャッシュフロー:
$-7.75M
1週間 パフォーマンス:
+0.08%
1か月 パフォーマンス:
-23.72%
6か月 パフォーマンス:
-65.19%
1年 パフォーマンス:
-89.96%
1日の値動き範囲:
$1.16
$1.24
1週間の範囲:
$1.0501
$1.45
52週間の値動き範囲:
$1.0501
$13.35
Dermata Therapeutics Inc Stock (DRMA) Company Profile
名前
Dermata Therapeutics Inc
セクター
電話
(858)-223-0882
住所
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
DRMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| DRMA | 1.1709 | 2.43M | 0 | -9.82M | -7.75M | -8.02 |
| VRTX | 449.99 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.40 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 593.04 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.04 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.32 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Dermata Therapeutics Inc (DRMA) 最新ニュース
ARMISTICE CAPITAL, LLC Increases Stake in Dermata Therapeutics I - GuruFocus.com
Dermata Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Dermata Therapeutics stock hits 52-week low at $1.2 amid steep decline - Investing.com UK
Earnings Flash (DRMA) DERMATA THERAPEUTICS Reports Q3 Loss $-2.04 - Marketscreener.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - AccessWire
Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024 - The Manila Times
Dermata stock hits 52-week low at $1.22 amid market challenges - Investing.com Australia
Sponge Power: Dermata's Revolutionary Acne Treatment Trial Results Due In 2025 - RTTNews
Analyzing DRMA’s price-to-book ratio for the last quarter - US Post News
Dermata stock hits 52-week low at $1.28 amid market challenges - Investing.com UK
Acne Vulgaris Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2024-2034), States DelveInsight | Clinuvel Pharma, Novan, Dermata Therapeutics, ioPharmX, Bausch Health - Barchart
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 - AccessWire
Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 3.2% - Defense World
How does Dianthus Therapeutics Inc (DNTH) change from a tortoise to a hare? - SETE News
Ameritas Investment Partners Inc. Has $1.82 Million Stake in Dolby Laboratories, Inc. (NYSE:DLB) - Defense World
How to interpret Design Therapeutics Inc (DSGN)’s stock chart patterns - US Post News
The Dixie Group (NASDAQ:DXYN) Earns Hold Rating from Analysts at StockNews.com - Defense World
Darden Restaurants, Inc. (NYSE:DRI) Holdings Raised by XTX Topco Ltd - Defense World
Darden shares steady on neutral rating from Piper Sandler - Investing.com India
Darden stock 'ready to run' with delivery boost and sales initiativesBTIG By Investing.com - Investing.com South Africa
Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga
Argent Trust Co Has $533,000 Stock Position in Darden Restaurants, Inc. (NYSE:DRI) - Defense World
Diamondback Energy 12.77M share Spot Secondary priced at $178.00 - TipRanks
Darden price target raised to $195 from $185 at Truist - TipRanks
Dianthus Therapeutics (NASDAQ:DNTH) Trading Up 7.5% - MarketBeat
Analytical Overview: Dermata Therapeutics Inc (DRMA)’s Ratios Tell a Financial Story - The Dwinnex
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - Kilgore News Herald
A Look at Dermata Therapeutics Inc (DRMA) Shares in the Recent Past Indicates Growth - SETE News
Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan
Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - StockTitan
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga
Entero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary - Benzinga
Acne Vulgaris Market Size is Set for Rapid Growth as Innovative - openPR
Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 - StockTitan
Prepare Yourself for Liftoff: Dermata Therapeutics Inc (DRMA) - SETE News
Can you now get a good deal on Dermata Therapeutics Inc’s shares? - US Post News
Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 1.16 Increase, Closing at 1.74 - The Dwinnex
Axillary Hyperhidrosis Market Expected to Experience Major - openPR
Maxim cuts Dermata Therapeutics stock target, retains buy on dilution risk - Investing.com India
Maxim Group Lowers Dermata Therapeutics (NASDAQ:DRMA) Price Target to $6.00 - Defense World
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Lags Revenue Estimates - MSN
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - Yahoo Finance
3 Penny Stocks to Watch Now, 8/6/24 - TipRanks
Take off with Dermata Therapeutics Inc (DRMA): Get ready for trading - SETE News
Dermata Therapeutics expands offering by $505,000 - Investing.com Australia
Dermata Therapeutics Inc [DRMA] moved up 44.19: Why It’s Important - The DBT News
Daily Market Movement: Dermata Therapeutics Inc (DRMA) Sees a 44.19 Increase, Closing at 2.48 - The Dwinnex
Why did Dermata Therapeutics Inc (NASDAQ: DRMA) surge today ? - BP Journal
DRMA’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Dermata Therapeutics Inc (DRMA) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):